Clovis Oncology Inc (NASDAQ:CLVS) - Share price - Overview

Stock Report

Clovis Oncology Inc CLVS

Last Price
$60.94

Day Change
-0.58|-0.94%

As of 24/11/2017
15:24:26 EST | USD
Minimum 15 Minutes Delay.

Last Close61.52
Day Range60.63 - 62.00
Mkt Cap3.10Bil
52-Wk Range34.04 - 99.45
Yield %-
ISINUS1894641000
Volume274,764
P/E-7.41
P/S70.42
P/CF-10.77

Share Price

Financials
201420152016
More ...
Income Statement
Revenue13.630.000.08
Operating Income-158.46-376.72-372.73
Net Income-160.03-352.86-349.14
Basic EPS-4.72-9.79-9.07
Avg. Diluted Shares Outstanding343638
Balance Sheet
Current Assets491.17539.70279.41
Non Current Assets295.03173.6985.15
Total Assets786.21713.39364.56
Current Liabilities47.7775.5865.60
Total Liabilities454.58412.74368.19
Total Equity331.63300.65-3.63
Cash Flow
Operating Cash Flow-117.05-253.07-266.68
Capital Expenditure-2.29-3.04-0.77
Free Cash Flow-119.34-256.10-267.45

In millions, except "Basic EPS". Currency is USD.

Company Profile

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

278
Key Stats
More ...
Price/Earning TTM-7.48
Price/Book10.35
Price/Sales TTM117.70
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-477,862.82
Net Margin % TTM-447,611.54
ROE TTM-235.10
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.